BioTryp Therapeutics
PrivateLast Round
Grant
Nov 24, 2025
Total Funding Raised
$940,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioTryp Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in November 2025.
BioTryp Therapeutics is a biotechnology company developing novel oral antibiofilm therapies for bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioTryp Therapeutics Comparables
Compare BioTryp Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Disperazol Pharma ApS | 88% | |
| Fimbrion Therapeutics | 81% | |
| Resistia | 80% |
For institutional investors. Book with your work email.
BioTryp Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 24, 2025 | ||||
| Pre Seed | Aug 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioTryp Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders at the University of Cambridge | Pre Seed |
| QUBIS | Pre Seed |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate UK | Grant |
| Cambridge Enterprise | Pre Seed |
| Parkwalk Advisors | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2025
$540K raised from Innovate UK and NRC IRAP.
- Aug 15, 2024
$400K raised from Parkwalk Advisors and QUBIS.
For institutional investors. Book with your work email.
BioTryp Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioTryp Therapeutics's valuation, stock price, and market status.
Is BioTryp Therapeutics a public or private company?
BioTryp Therapeutics is a private company.
What is the current stock price of BioTryp Therapeutics?
BioTryp Therapeutics is a private company, so its shares have no public market price. Caplight tracks BioTryp Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioTryp Therapeutics worth (valuation)?
Valuation information for BioTryp Therapeutics is not publicly available.
Can I buy BioTryp Therapeutics stock?
BioTryp Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioTryp Therapeutics's last funding round?
BioTryp Therapeutics's most recent funding round was Grant on November 24, 2025.
Who are the main investors in BioTryp Therapeutics?
Key investors in BioTryp Therapeutics include Founders at the University of Cambridge, QUBIS, National Research Council Canada Industrial Research Assistance Program, Innovate UK, Cambridge Enterprise.
Will BioTryp Therapeutics IPO soon?
No public IPO plans have been announced for BioTryp Therapeutics.
How can I track BioTryp Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in BioTryp Therapeutics's shares on secondary markets.